Epigenetic regulation of the circadian clock: role of 5-aza-2′-deoxycytidine

被引:12
|
作者
Tomita, Tatsunosuke [1 ]
Kurita, Ryoji [1 ]
Onishi, Yoshiaki [1 ]
机构
[1] DBT AIST Int Lab Adv Biomed, Natl Inst Adv Ind Sci & Technol AIST, Biomed Res Inst, Higashi 1-1-1, Tsukuba, Ibaraki 3058566, Japan
关键词
DNA METHYLATION; DEREGULATED EXPRESSION; TRANSCRIPTION FACTORS; PROMOTER METHYLATION; MYELOID-LEUKEMIA; GENE; BINDING; CHROMATIN; CANCER; BMAL1;
D O I
10.1042/BSR20170053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have been investigating transcriptional regulation of the BMAL1 gene, a critical component of the mammalian clock system including DNA methylation. Here, a more detailed analysis of the regulation of DNA methylation of BMAL1 proceeded in RPMI8402 lymphoma cells. We found that CpG islands in the BMAL1 and the PER2 promoters were hyper-and hypomethylated, respectively and that 5-aza-2'-deoxycytidine (aza-dC) not only enhanced PER2 gene expression but also PER2 oscillation within 24 h in RPMI8402 cells. That is, such hypermethylation of CpG islands in the BMAL1 promoter restricted PER2 expression which was recovered by aza-dC within 1 day in these cells. These results suggest that the circadian clock system can be recovered through BMAL1 expression induced by aza-dC within a day. The RPIB9 promoter of RPMI8402 cells, which is a methylation hotspot in lymphoblastic leukemia, was also hypermethylated and aza-dC gradually recovered RPIB9 expression in 3 days. In addition, methylation-specific PCR revealed a different degree of aza-dC-induced methylation release between BMAL1 and RPIB9. These results suggest that the aza-dC-induced recovery of gene expression from DNA methylation is dependent on a gene, for example the rapid response to demethylation by the circadian system, and thus, is of importance to clinical strategies for treating cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Epigenetic interactive regulation and synergistic action of Trichostatin A, 5-aza-2′-deoxycytidine
    Meng, Fanliang
    Sun, Guigin
    Zhong, Mei
    Yu, Yanhong
    Brewers, Molly A.
    CANCER RESEARCH, 2011, 71
  • [2] Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine)
    Momparler, RL
    SEMINARS IN ONCOLOGY, 2005, 32 (05) : 443 - 451
  • [3] Influencing Epigenetic Information with a Hydrolytically Stable Carbocyclic 5-Aza-2′-deoxycytidine
    Wildenhof, Thomas M.
    Schiffers, Sarah
    Traube, Franziska R.
    Mayer, Peter
    Carell, Thomas
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (37) : 12984 - 12987
  • [4] KINETICS OF PHOSPHORYLATION OF 5-AZA-2'-DEOXYCYTIDINE BY DEOXYCYTIDINE KINASE
    MOMPARLER, RL
    DERSE, D
    BIOCHEMICAL PHARMACOLOGY, 1979, 28 (08) : 1443 - 1444
  • [5] Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)
    Momparler, RL
    SEMINARS IN HEMATOLOGY, 2005, 42 (03) : S9 - S16
  • [6] AN ANALYTICAL STUDY OF 5-AZA-2'-DEOXYCYTIDINE
    TOMANKOVA, H
    ZYKA, J
    PILECKOVA, Z
    MICROCHEMICAL JOURNAL, 1984, 29 (03) : 333 - 340
  • [7] Effects of 5-Aza-2'-deoxycytidine on hormone secretion and epigenetic regulation in sika deer ovarian granulosa cells
    Chen, Xiumin
    Xing, Mingjie
    REPRODUCTION IN DOMESTIC ANIMALS, 2021, 56 (02) : 360 - 369
  • [8] 5-aza-2′-deoxycytidine in myelodysplasia.
    Kell, WJ
    Burnett, AK
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 64 - 64
  • [9] Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
    Maryse Lemaire
    Guy G Chabot
    Noël JM Raynal
    Louise F Momparler
    Annie Hurtubise
    Mark L Bernstein
    Richard L Momparler
    BMC Cancer, 8
  • [10] Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
    Lemaire, Maryse
    Chabot, Guy G.
    Raynal, Noel J. M.
    Momparler, Louise F.
    Hurtubise, Annie
    Bernstein, Mark L.
    Momparler, Richard L.
    BMC CANCER, 2008, 8 (1)